Pathfinder Cell Therapy (Pathfinder Cell Therapy) Total Stockholders Equity : $-6.73 Mil (As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Total Stockholders Equity?

Pathfinder Cell Therapy's Total Stockholders Equity for the quarter that ended in Sep. 2015 was $-6.73 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pathfinder Cell Therapy's Book Value per Share for the quarter that ended in Sep. 2015 was $-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pathfinder Cell Therapy's Debt-to-Equity for the quarter that ended in Sep. 2015 was -0.80.

Pathfinder Cell Therapy Total Stockholders Equity Historical Data

The historical data trend for Pathfinder Cell Therapy's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Total Stockholders Equity Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Total Stockholders Equity

Get a 7-Day Free Trial

-1.13

-0.71

-2.85

-4.55

-5.94

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Total Stockholders Equity	Get a 7-Day Free Trial															-5.65	-5.94	-6.22	-6.44	-6.73

Pathfinder Cell Therapy (OTCPK:PFND) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pathfinder Cell Therapy's Book Value per Share for the quarter that ended in Sep. 2015 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-6.73	-	0)	/	667.161
	=	-0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pathfinder Cell Therapy's Debt-to-Equity for the quarter that ended in Sep. 2015 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.413	+	0)	/	-6.73
	=	-0.80

Pathfinder Cell Therapy Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines